{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:42:02Z","timestamp":1773330122596,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T00:00:00Z","timestamp":1407542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00204-014-1320-9","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T03:33:05Z","timestamp":1407468785000},"page":"1347-1358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism"],"prefix":"10.1007","volume":"89","author":[{"given":"Sofia P.","family":"Rebelo","sequence":"first","affiliation":[]},{"given":"Rita","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Estrada","sequence":"additional","affiliation":[]},{"given":"Valery","family":"Shevchenko","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Brito","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,8,9]]},"reference":[{"issue":"3","key":"1320_CR1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/dmd.109.030197","volume":"38","author":"S Antherieu","year":"2010","unstructured":"Antherieu S, Chesne C, Li R, Camus S, Lahoz A, Picazo L, Turpeinen M, Tolonen A, Uusitalo J, Guguen-Guillouzo C, Guillouzo A (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38(3):516\u2013525. doi: 10.1124\/dmd.109.030197","journal-title":"Drug Metab Dispos"},{"key":"1320_CR2","author":"T Bhatt","year":"2013","unstructured":"Bhatt T, Rizvi A, Batta SP, Kataria S, Jamora C (2013) Signaling and mechanical roles of E-cadherin. Cell Commun Adhes. doi: 10.3109\/15419061.2013.854778","journal-title":"Cell Commun Adhes"},{"issue":"5","key":"1320_CR3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1525-1594.1988.tb02793.x","volume":"12","author":"ZH Cai","year":"1988","unstructured":"Cai ZH, Shi ZQ, O\u2019Shea GM, Sun AM (1988) Microencapsulated hepatocytes for bioartificial liver support. Artif Organs 12(5):388\u2013393","journal-title":"Artif Organs"},{"issue":"4","key":"1320_CR4","doi-asserted-by":"crossref","first-page":"e62032","DOI":"10.1371\/journal.pone.0062032","volume":"8","author":"SH Capone","year":"2013","unstructured":"Capone SH, Dufresne M, Rechel M, Fleury MJ, Salsac AV, Paullier P, Daujat-Chavanieu M, Legallais C (2013) Impact of alginate composition: from bead mechanical properties to encapsulated HepG2\/C3A cell activities for in vivo implantation. PLoS ONE 8(4):e62032. doi: 10.1371\/journal.pone.0062032","journal-title":"PLoS ONE"},{"key":"1320_CR5","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/srep03751","volume":"4","author":"JP Celli","year":"2014","unstructured":"Celli JP, Rizvi I, Blanden AR, Massodi I, Glidden MD, Pogue BW, Hasan T (2014) An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci Rep 4:3751","journal-title":"Sci Rep"},{"issue":"4","key":"1320_CR6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.21536","volume":"45","author":"V Cerec","year":"2007","unstructured":"Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, Drenou B, Gripon P, Kremsdorf D, Guguen-Guillouzo C, Corlu A (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45(4):957\u2013967. doi: 10.1002\/hep.21536","journal-title":"Hepatology"},{"issue":"1","key":"1320_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ten.a.2007.0131","volume":"14","author":"N Cheng","year":"2008","unstructured":"Cheng N, Wauthier E, Reid LM (2008) Mature human hepatocytes from ex vivo differentiation of alginate-encapsulated hepatoblasts. Tissue Eng Part A 14(1):1\u20137. doi: 10.1089\/ten.a.2007.0131","journal-title":"Tissue Eng Part A"},{"issue":"3","key":"1320_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biomaterials.2007.09.016","volume":"29","author":"Y Du","year":"2008","unstructured":"Du Y, Han R, Wen F, Ng San San S, Xia L, Wohland T, Leo HL, Yu H (2008) Synthetic sandwich culture of 3D hepatocyte monolayer. Biomaterials 29(3):290\u2013301. doi: 10.1016\/j.biomaterials.2007.09.016","journal-title":"Biomaterials"},{"issue":"5","key":"1320_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1089\/ten.2006.12.1357","volume":"12","author":"T Elkayam","year":"2006","unstructured":"Elkayam T, Amitay-Shaprut S, Dvir-Ginzberg M, Harel T, Cohen S (2006) Enhancing the drug metabolism activities of C3A\u2014a human hepatocyte cell line\u2014by tissue engineering within alginate scaffolds. Tissue Eng 12(5):1357\u20131368. doi: 10.1089\/ten.2006.12.1357","journal-title":"Tissue Eng"},{"issue":"4","key":"1320_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","volume":"126","author":"AJ Engler","year":"2006","unstructured":"Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126(4):677\u2013689. doi: 10.1016\/j.cell.2006.06.044","journal-title":"Cell"},{"key":"1320_CR11","doi-asserted-by":"crossref","unstructured":"Gerets HHJ, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, Atienzar FA (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol (28):69\u201387. doi: 10.1007\/s10565-011-9208-4","DOI":"10.1007\/s10565-011-9208-4"},{"issue":"8","key":"1320_CR12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gomez-Lechon MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Haussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhutter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, Lecluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stober R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315\u20131530. doi: 10.1007\/s00204-013-1078-5","journal-title":"Arch Toxicol"},{"issue":"24","key":"1320_CR13","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99(24):15655\u201315660. doi: 10.1073\/pnas.232137699","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1320_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/toxsci\/kft021","volume":"133","author":"P Gunness","year":"2013","unstructured":"Gunness P, Mueller D, Shevchenko V, Heinzle E, Ingelman-Sundberg M, Noor F (2013) 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci 133(1):67\u201378. doi: 10.1093\/toxsci\/kft021","journal-title":"Toxicol Sci"},{"issue":"6","key":"1320_CR15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","volume":"38","author":"SN Hart","year":"2010","unstructured":"Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, Zhong XB (2010) A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 38(6):988\u2013994. doi: 10.1124\/dmd.109.031831","journal-title":"Drug Metab Dispos"},{"key":"1320_CR16","author":"Y Higuchi","year":"2013","unstructured":"Higuchi Y, Kawai K, Yamazaki H, Nakamura M, Bree F, Guguen-Guillouzo C, Suemizu H (2013) The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice. Xenobiotica. doi: 10.3109\/00498254.2013.836257","journal-title":"Xenobiotica"},{"issue":"10","key":"1320_CR17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","volume":"43","author":"R Hoekstra","year":"2011","unstructured":"Hoekstra R, Nibourg GA, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Lamers WH, Elferink RP, Chamuleau RA (2011) The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 43(10):1483\u20131489. doi: 10.1016\/j.biocel.2011.06.011","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"1320_CR18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1124\/dmd.112.049098","volume":"41","author":"R Hoekstra","year":"2013","unstructured":"Hoekstra R, Nibourg GA, van der Hoeven TV, Plomer G, Seppen J, Ackermans MT, Camus S, Kulik W, van Gulik TM, Elferink RP, Chamuleau RA (2013) Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide. Drug Metab Dispos 41(3):562\u2013567. doi: 10.1124\/dmd.112.049098","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1320_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/bit.21747","volume":"100","author":"U Hofmann","year":"2008","unstructured":"Hofmann U, Maier K, Niebel A, Vacun G, Reuss M, Mauch K (2008) Identification of metabolic fluxes in hepatic cells from transient 13C-labeling experiments: Part I. Experimental observations. Biotechnol Bioeng 100(2):344\u2013354","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"1320_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01454004","volume":"103","author":"K Jungermann","year":"1995","unstructured":"Jungermann K (1995) Zonation of metabolism and gene expression in liver. Histochem Cell Biol 103(2):81\u201391","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"1320_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3727\/000000007783464489","volume":"16","author":"T Koizumi","year":"2007","unstructured":"Koizumi T, Aoki T, Kobayashi Y, Yasuda D, Izumida Y, Jin Z, Nishino N, Shimizu Y, Kato H, Murai N, Niiya T, Enami Y, Mitamura K, Yamamoto T, Kusano M (2007) Long-term maintenance of the drug transport activity in cryopreservation of microencapsulated rat hepatocytes. Cell Transplant 16(1):67\u201373","journal-title":"Cell Transplant"},{"issue":"1","key":"1320_CR22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.taap.2011.07.013","volume":"256","author":"S-F Lan","year":"2011","unstructured":"Lan S-F, Starly B (2011) Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol Appl Pharmacol 256(1):62\u201372","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1\u20132","key":"1320_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","volume":"28","author":"M Vee Le","year":"2006","unstructured":"Le Vee M, Jigorel E, Glaise D, Gripon P, Guguen-Guillouzo C, Fardel O (2006) Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur J Pharm Sci 28(1\u20132):109\u2013117. doi: 10.1016\/j.ejps.2006.01.004","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1320_CR24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.tiv.2013.07.003","volume":"27","author":"M Vee Le","year":"2013","unstructured":"Le Vee M, Noel G, Jouan E, Stieger B, Fardel O (2013) Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells. Toxicol In Vitro 27(6):1979\u20131986. doi: 10.1016\/j.tiv.2013.07.003","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"1320_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10408444.2012.682115","volume":"42","author":"EL LeCluyse","year":"2012","unstructured":"LeCluyse EL, Witek RP, Andersen ME, Powers MJ (2012) Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 42(6):501\u2013548. doi: 10.3109\/10408444.2012.682115","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"1320_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","volume":"130","author":"SB Leite","year":"2012","unstructured":"Leite SB, Wilk-Zasadna I, Zaldivar JM, Airola E, Reis-Fernandes MA, Mennecozzi M, Guguen-Guillouzo C, Chesne C, Guillou C, Alves PM, Coecke S (2012) Three-dimensional HepaRG model as an attractive tool for toxicity testing. Toxicol Sci 130(1):106\u2013116. doi: 10.1093\/toxsci\/kfs232","journal-title":"Toxicol Sci"},{"issue":"3","key":"1320_CR27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1872-034X.2007.00255.x","volume":"38","author":"G Lengyel","year":"2008","unstructured":"Lengyel G, Veres Z, Tugyi R, Vereczkey L, Molnar T, Glavinas H, Krajcsi P, Jemnitz K (2008) Modulation of sinusoidal and canalicular elimination of bilirubin-glucuronides by rifampicin and other cholestatic drugs in a sandwich culture of rat hepatocytes. Hepatol Res 38(3):300\u2013309. doi: 10.1111\/j.1872-034X.2007.00255.x","journal-title":"Hepatol Res"},{"issue":"5","key":"1320_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2184.2010.00692.x","volume":"43","author":"N Lin","year":"2010","unstructured":"Lin N, Lin J, Bo L, Weidong P, Chen S, Xu R (2010) Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold. Cell Prolif 43(5):427\u2013434. doi: 10.1111\/j.1365-2184.2010.00692.x","journal-title":"Cell Prolif"},{"issue":"3","key":"1320_CR29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/bit.21599","volume":"99","author":"D Mavri-Damelin","year":"2008","unstructured":"Mavri-Damelin D, Damelin LH, Eaton S, Rees M, Selden C, Hodgson HJ (2008) Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 99(3):644\u2013651. doi: 10.1002\/bit.21599","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"1320_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/ten.a.2007.0058","volume":"14","author":"R McClelland","year":"2008","unstructured":"McClelland R, Wauthier E, Uronis J, Reid L (2008) Gradients in the liver\u2019s extracellular matrix chemistry from periportal to pericentral zones: influence on human hepatic progenitors. Tissue Eng Part A 14(1):59\u201370. doi: 10.1089\/ten.a.2007.0058","journal-title":"Tissue Eng Part A"},{"key":"1320_CR31","author":"D Mueller","year":"2013","unstructured":"Mueller D, Kramer L, Hoffmann E, Klein S, Noor F (2013) 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol In Vitro. doi: 10.1016\/j.tiv.2013.06.024","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"1320_CR32","doi-asserted-by":"crossref","first-page":"e38778","DOI":"10.1371\/journal.pone.0038778","volume":"7","author":"GA Nibourg","year":"2012","unstructured":"Nibourg GA, Chamuleau RA, van der Hoeven TV, Maas MA, Ruiter AF, Lamers WH, Oude Elferink RP, van Gulik TM, Hoekstra R (2012) Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PLoS ONE 7(6):e38778. doi: 10.1371\/journal.pone.0038778","journal-title":"PLoS ONE"},{"issue":"4","key":"1320_CR33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00204-011-0782-2","volume":"86","author":"R Pal","year":"2012","unstructured":"Pal R, Mamidi MK, Das AK, Bhonde R (2012) Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol 86(4):651\u2013661. doi: 10.1007\/s00204-011-0782-2","journal-title":"Arch Toxicol"},{"issue":"4","key":"1320_CR34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2004.01.002","volume":"126","author":"R Parent","year":"2004","unstructured":"Parent R, Marion MJ, Furio L, Trepo C, Petit MA (2004) Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126(4):1147\u20131156","journal-title":"Gastroenterology"},{"issue":"7","key":"1320_CR35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(03)00002-9","volume":"65","author":"NC Santos","year":"2003","unstructured":"Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65(7):1035\u20131041","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1320_CR36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.24707","volume":"55","author":"A Schulze","year":"2012","unstructured":"Schulze A, Mills K, Weiss TS, Urban S (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55(2):373\u2013383. doi: 10.1002\/hep.24707","journal-title":"Hepatology"},{"issue":"2","key":"1320_CR37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.abb.2004.02.008","volume":"424","author":"T Su","year":"2004","unstructured":"Su T, Waxman DJ (2004) Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. Arch Biochem Biophys 424(2):226\u2013234. doi: 10.1016\/j.abb.2004.02.008","journal-title":"Arch Biochem Biophys"},{"key":"1320_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02783739","volume":"10","author":"AM Sun","year":"1984","unstructured":"Sun AM, O\u2019Shea GM, Goosen MF (1984) Injectable microencapsulated islet cells as a bioartificial pancreas. Appl Biochem Biotechnol 10:87\u201399","journal-title":"Appl Biochem Biotechnol"},{"issue":"7","key":"1320_CR39","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.biomaterials.2012.11.029","volume":"34","author":"K Takayama","year":"2013","unstructured":"Takayama K, Kawabata K, Nagamoto Y, Kishimoto K, Tashiro K, Sakurai F, Tachibana M, Kanda K, Hayakawa T, Furue MK, Mizuguchi H (2013) 3D spheroid culture of hESC\/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34(7):1781\u20131789. doi: 10.1016\/j.biomaterials.2012.11.029","journal-title":"Biomaterials"},{"key":"1320_CR40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-385233-5.00005-2","volume":"97","author":"C Torre","year":"2010","unstructured":"Torre C, Perret C, Colnot S (2010) Molecular determinants of liver zonation. Prog Mol Biol Transl Sci 97:127\u2013150. doi: 10.1016\/B978-0-12-385233-5.00005-2","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"1320_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bit.22920","volume":"108","author":"RM Tostoes","year":"2011","unstructured":"Tostoes RM, Leite SB, Miranda JP, Sousa M, Wang DI, Carrondo MJ, Alves PM (2011) Perfusion of 3D encapsulated hepatocytes\u2014a synergistic effect enhancing long-term functionality in bioreactors. Biotechnol Bioeng 108(1):41\u201349. doi: 10.1002\/bit.22920","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"1320_CR42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yexcr.2014.01.017","volume":"323","author":"C Wenzel","year":"2014","unstructured":"Wenzel C, Riefke B, Grundemann S, Krebs A, Christian S, Prinz F, Osterland M, Golfier S, Rase S, Ansari N, Esner M, Bickle M, Pampaloni F, Mattheyer C, Stelzer EH, Parczyk K, Prechtl S, Steigemann P (2014) 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Exp Cell Res 323(1):131\u2013143","journal-title":"Exp Cell Res"},{"issue":"4","key":"1320_CR43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.24760","volume":"55","author":"RM Tostoes","year":"2012","unstructured":"Tostoes RM, Leite SB, Serra M, Jensen J, Bjorquist P, Carrondo MJ, Brito C, Alves PM (2012) Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology (Baltimore, Md) 55(4):1227\u20131236","journal-title":"Hepatology (Baltimore, Md)"},{"key":"1320_CR44","author":"J You","year":"2013","unstructured":"You J, Park SA, Shin DS, Patel D, Raghunathan VK, Kim M, Murphy CJ, Tae G, Revzin A (2013) Characterizing the effects of heparin gel stiffness on function of primary hepatocytes. Tissue Eng Part A. doi: 10.1089\/ten.TEA.2012.0681","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"1320_CR45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","volume":"304","author":"MJ Zamek-Gliszczynski","year":"2003","unstructured":"Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KL (2003) Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304(2):801\u2013809. doi: 10.1124\/jpet.102.044107","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1320-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-014-1320-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1320-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:17:03Z","timestamp":1558624623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-014-1320-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,9]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1007\/s00204-014-1320-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,9]]}}}